Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas

por Cox, Samantha J., O’Cathail, Sean M., Coles, Bernadette, Crosby, Tom, Mukherjee, Somnath
Publicado 2017

NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch

por O’Cathail, Séan M., Wu, Chieh-Hsi, Thomas, Rachael, Hawkins, Maria A., Maughan, Tim S., Lewis, Annabelle
Publicado 2021

Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity

por Smith, Thomas, O’Cathail, Sean M., Silverman, Sabrina, Robinson, Maxwell, Tsang, Yatman, Harrison, Mark, Hawkins, Maria A.
Publicado 2020

Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea

por O'Cathail, Sean M., Adams, Richard, Hawkins, Maria A., Sebag-Montefiore, David, Marijnen, Corrie A.M., Fokas, Emmanouil
Publicado 2023

Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization

por O’Cathail, Sean M., Pokrovska, Tzveta D., Maughan, Timothy S., Fisher, Kerry D., Seymour, Leonard W., Hawkins, Maria A.
Publicado 2017

CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods

por Rayner, Emily, Durin, Mary-Anne, Thomas, Rachael, Moralli, Daniela, O'Cathail, Sean M., Tomlinson, Ian, Green, Catherine M., Lewis, Annabelle
Publicado 2019

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes

por Cooke, Rosie, Camilleri, Philip, Chu, Kwun-Ye, O'Cathail, Séan M., Robinson, Maxwell, Van Den Heuvel, Frank, Hawkins, Maria A.
Publicado 2020

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer

por Devlin, Lynsey, Grocutt, Laura, Hunter, Bianca, Chemu, Hiwot, Duffton, Aileen, McDonald, Alec, Macleod, Nicholas, McLoone, Philip, O'Cathail, Sean M.
Publicado 2022

Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy

por O'Cathail, Sean M., Smith, Thomas, Owens, Rob, Zeniou, Anthi, Tsang, Yatman, Holyoake, Daniel L.P., Murray, Louise, Harrison, Mark, Hawkins, Maria A.
Publicado 2020

A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced...

por O’Cathail, Séan M., Davis, Steven, Holmes, Jane, Brown, Richard, Fisher, Kerry, Seymour, Leonard, Adams, Richard, Good, James, Sebag-Montefiore, David, Maughan, Tim, Hawkins, Maria A.
Publicado 2020

An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials

por Pinato, David J., Stavraka, Chara, Flynn, Michael J., Forster, Martin D., O'Cathail, Séan M., Seckl, Michael J., Kristeleit, Rebecca S., Olmos, David, Turnbull, Samantha J., Blagden, Sarah P.
Publicado 2014

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

por Hanna, Catherine R., O’Cathail, Sean M., Graham, Janet S., Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R., Kelly, Caroline A., Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J., Thomson, Fiona, Adams, Richard A., Roxburgh, Campbell S. D.
Publicado 2021

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

por Hanna, Catherine R., O’Cathail, Sean M., Graham, Janet S., Saunders, Mark, Samuel, Leslie, Harrison, Mark, Devlin, Lynsey, Edwards, Joanne, Gaya, Daniel R., Kelly, Caroline A., Lewsley, Liz-Anne, Maka, Noori, Morrison, Paula, Dinnett, Louise, Dillon, Susan, Gourlay, Jacqueline, Platt, Jonathan J., Thomson, Fiona, Adams, Richard A., Roxburgh, Campbell S. D.
Publicado 2021

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

por Beach, Callum, MacLean, David, Majorova, Dominika, Melemenidis, Stavros, Nambiar, Dhanya K., Kim, Ryan K., Valbuena, Gabriel N., Guglietta, Silvia, Krieg, Carsten, Darvish-Damavandi, Mahnaz, Suwa, Tatsuya, Easton, Alistair, Hillson, Lily V.S., McCulloch, Ashley K., McMahon, Ross K., Pennel, Kathryn, Edwards, Joanne, O’Cathail, Sean M., Roxburgh, Campbell S., Domingo, Enric, Moon, Eui Jung, Jiang, Dadi, Jiang, Yanyan, Zhang, Qingyang, Koong, Albert C., Woodruff, Trent M., Graves, Edward E., Maughan, Tim, Buczacki, Simon J.A., Stucki, Manuel, Le, Quynh-Thu, Leedham, Simon J., Giaccia, Amato J., Olcina, Monica M.
Publicado 2023